These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 37239020)

  • 1. The Impact of microRNAs on Mitochondrial Function and Immunity: Relevance to Parkinson's Disease.
    Guedes BFS; Cardoso SM; Esteves AR
    Biomedicines; 2023 May; 11(5):. PubMed ID: 37239020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Progress of Microbiota-Gut-Brain Axis in Parkinson's Disease.
    Zhang W; Ye Y; Song J; Sang T; Xia T; Xie L; Qiu X; Zeng Q; Luo X
    J Integr Neurosci; 2023 Oct; 22(6):157. PubMed ID: 38176929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA Dysregulation in Parkinson's Disease: A Narrative Review.
    Nies YH; Mohamad Najib NH; Lim WL; Kamaruzzaman MA; Yahaya MF; Teoh SL
    Front Neurosci; 2021; 15():660379. PubMed ID: 33994934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.
    Sharma S; Awasthi A; Singh S
    Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut brain axis: an insight into microbiota role in Parkinson's disease.
    Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
    Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment.
    Salim S; Ahmad F; Banu A; Mohammad F
    J Adv Res; 2023 Aug; 50():83-105. PubMed ID: 36332796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis.
    Chen SJ; Lin CH
    J Biomed Sci; 2022 Jul; 29(1):54. PubMed ID: 35897024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson's disease.
    Mohammed OA; Elballal MS; El-Husseiny AA; Khidr EG; El Tabaa MM; Elazazy O; Abd-Elmawla MA; Elesawy AE; Ibrahim HM; Abulsoud AI; El-Dakroury WA; Abdel Mageed SS; Elrebehy MA; Nomier Y; Abdel-Reheim MA; El-Husseiny HM; Mahmoud AMA; Saber S; Doghish AS
    Pathol Res Pract; 2024 Jan; 253():155023. PubMed ID: 38081104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring Fecal Microbiota Transplantation for Modulating Inflammation in Parkinson's Disease: A Review of Inflammatory Markers and Potential Effects.
    Sadowski K; Zając W; Milanowski Ł; Koziorowski D; Figura M
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-gut-microbiota axis in Parkinson's disease: A historical review and future perspective.
    Dong S; Sun M; He C; Cheng H
    Brain Res Bull; 2022 Jun; 183():84-93. PubMed ID: 35245613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
    Koutzoumis DN; Vergara M; Pino J; Buddendorff J; Khoshbouei H; Mandel RJ; Torres GE
    Exp Neurol; 2020 Mar; 325():113159. PubMed ID: 31843492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson's disease.
    Li Q; Meng LB; Chen LJ; Shi X; Tu L; Zhou Q; Yu JL; Liao X; Zeng Y; Yuan QY
    Front Neurol; 2023; 14():1185375. PubMed ID: 37305758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroacupuncture at ST25 corrected gut microbial dysbiosis and SNpc lipid peroxidation in Parkinson's disease rats.
    Hu XM; Song LZ; Zhang ZZ; Ruan X; Li HC; Yu Z; Huang L
    Front Microbiol; 2024; 15():1358525. PubMed ID: 38450172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Gut-Brain Axis and Its Relation to Parkinson's Disease: A Review.
    Klann EM; Dissanayake U; Gurrala A; Farrer M; Shukla AW; Ramirez-Zamora A; Mai V; Vedam-Mai V
    Front Aging Neurosci; 2021; 13():782082. PubMed ID: 35069178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNAs: Emerging Targets Regulating Oxidative Stress in the Models of Parkinson's Disease.
    Xie Y; Chen Y
    Front Neurosci; 2016; 10():298. PubMed ID: 27445669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
    Dogra N; Mani RJ; Katare DP
    Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.